Skip to main content

Table 1 Dose prescription depending on TNM stage and patient eligibility for concomitant chemotherapy

From: ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol

 

Dose to Tumor

Pathological LN < 20 mm

Pathological LN ≥ 20 mm

Elective areas

T1N0

T1-4 N1-3

T1-4 N1-3 (No chemo)

54 Gy/30 fx

60 Gy/30 fx

64 Gy/32 fx

-

54 Gy/30 fx

64 Gy/32 fx

-

60 Gy/30 fx

64 Gy/32 fx

48 Gy/30 fx

48 Gy/30 fx

51,2 Gy/32 fx